Designações Órfãs por área geográfica
- Dantrolene sodium
- Darinaparsina
- Dasatinib
- Daunorubicina liposoma
- Daunorubicin (liposomal)
- Decitabina
- Deferasirox
- Deferoxamine mesilate
- Deferriprona
- Defibrotide
- Deforolimus
- Denileukina diftitox
- Denufosol tetrasodium
- Deoxyribose phosphorothioate (5´-tct-ccc-agc-gtg-cgc-cat-3´)
- Desmoglein 3 synthetic peptide
- Dexametasona (comprimidos de 40mg)
- Dexametasona (implante intravítreo)
- Dexamethasone sodium phosphate encapsulated in human erythrocytes
- Dexrazoxane
- Di-cloridrato de N-(5-ter-butilisoxazol-3-il)-N'-{4-[7-(2-(morfolin-4-il)etoxi)imidazol [2,1-b][1,3]benzotiazol-2-il]fenil}ureia
- Dietanolamina de treprostinil
- Dihidrocloreto de 5-[1-(2,6 diclorobenzil)piperidina-4-il-metoxil]quinazolina 2,4-diamina
- Dimethyl sulfoxide
- Dinaciclib
- Dipalmitoilfosfatidilcolina, 1-palmitoil-2-oleoil-sn-glicero-3-fosfoglicerol, sal de sódio, surfactante sintético análogo da proteína C e surfactante sintético análogo da proteína B
- Diphenylcyclopropenone
- Donor lymphocyte preparation depleted of functional alloreactive T-cells
- Dornase alfa
- Doxorubicin (administered after synthetic double-stranded siRNA oligonucleotide directed against claudin-5 complexed with polyethyleneimine)
- Doxorubicin hydrochloride (drug eluting beads)
- Doxorubicin hydrochloride (liposomal)
- Doxorubicin hydrochloride (pegylated liposomal)
- Doxorubicin polyisohexylcyanoacrylate nanoparticles
- Drotrecogin alfa (activated)
- Duramycin
